The Journal of allergy and clinical immunology

The most recent articles from: J. Allergy Clin. Immunol. November 1999

J. Allergy Clin. Immunol. · Nov 1999

Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.

Fexofenadine hydrochloride (HCl) is a new H(1) antihistamine used twice daily in some countries. ⋯ Once-daily fexofenadine is thus a valuable addition to the nonsedating group of H(1) receptor antagonists currently available for the treatment of seasonal allergic rhinitis.

read on… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.